My glasses are green bud. I do see the reality.

They’re bringing all of you guys out of the gutters for this.

Wait until we’re current and pick up new buyers who can’t trade yet.

Expecting it. Hold tight.

Speak English much?

I know. I like to put in some facts here and there for new eyes.

Imagine when ITV-1 gets brought to the US market as a phase 4. I don’t think many have thought of that aspect.

From the PR:
“The Company's intent is to take the ITV-1 treatment, which has already successfully completed Phase III clinical trials at the Specialized Hospital for Active Treatment of Infectious and Parasite Diseases in Sofia, Bulgaria, through the permitting process and begin the process of gaining regulatory approval with the FDA in the United States.”

Most definitely.

Lol, yes they do. Sound like broken records on every ticker.

I have been here since the beginning of the year and have done a lot of research. You will not change my mind about anything.

Heard he also has close ties with the NIH.

The numbers work, they may not get back to everyone. I confirmed the address a couple of months ago and have talked to Harry personally as have others.

Congrats to all who held strong. This is what we’ve been waiting for.

He’ll get back to you in 2029. Lol.

Love your posts, just one correction. It is for HIV not AIDS.

I wouldn’t consider a tick down tanking.

Better than useless words from a useless mouth.

He is trying to get an immune booster supplement passed through the FDA. It utilizes some of the same properties as the treatment.

Looking good here friends. Feels like more sustainable movement.

You are confused madam.

A lot more buys than sells.

You’ve said plenty of other crap that is uncalled for.

You’re moving us up the BOB. Keep goin. ; )

I’ve thought the same. If something like that happens, hitting resistance, that’s when we go to the news outlets, flood social media, etc. Obviously when it’s ready.

I think this next update will be much more substantial.

The only thing Dimitar told me was the factory was 80% complete.

I think multi pennies is just a start. Just think about what this is and what it can do. Once it’s out, gains publicity, and becomes widely used it’s hard to say what the possibilities are.

I agree, I think current status will be coming sooner than a lot think. I can feel it in my nuggets.

Why is that?

That is my thought. They’re not actually selling a treatment, yet. Money has to come from somewhere.

I posted that particular company because they had an evaluation of potential profits from an HIV cure. If they’re doing COVID too then great. Interesting though that they’re a Dallas based company doing the same type of research.

Nice.

I’ve thought that but I’m afraid of swinging my ass out of a position. Lol.

I believe there is a lot coming here. I plan on holding beyond .00’s just for starters. Far too much potential with something of this nature.

Looked up another company in the Dallas area that is developing an HIV treatment and found Bioclonetics. They did an evaluation of the projected profit from a successful treatment.

No relation to ENZC that I know of, but just to show the possibilities.


“For purposes of evaluating the commercial potential that could result from making a treatment of the nature our therapy available, Navigant calculated the net profit that could be expected from the Company’s therapy used in the “Major Markets”, namely North American, Western and Central Europe, Eastern Europe and Central Asia, South and Southeast Asia and Latin America. In these regions there are 10.65 million HIV positive individuals. Assuming a penetration rate of 1% rising to a maximum 15% over a five-year period, net profit, calculated by Navigant Consulting, Inc. (NYSE: NCI), expected from making our treatment available to these 10.65 million HIV positive individuals would be $73.56 Billion in the first 10 years. Such net profit can be compared to the total net profit realized over the last 10 year period (2007-2016) by Merck ($63.54 Billion [http://financials.morningstar.com/ratios/r.html?t=MRK]) or Gilead ($90.59 Billion [http://financials.morningstar.com/ratios/r.html?t=GILD]).”

Link:
https://d19j0qt0x55bap.cloudfront.net/production/startups/59c19d09547a993f30001ef6/documents/offering_details/biocloneticsAmendedaudit.pdf

I suspect tomorrow will be a very interesting day.

They were fighting like hell to keep it under 005.

That’s was the chatter several months ago, the TA would have to buy back at some point. Possible.

He does have a lease at the address listed in the last 8K.

Hopefully we get some continuation and news.